In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe

被引：36
|
作者：
Jansen, W. T. A. [1 ]
Verel, A. [1 ]
Verhoef, J. [1 ]
Milatovic, D. [1 ]
机构：
[1] Univ Med Ctr, NL-3584 CX Utrecht, Netherlands
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2007年 / 51卷 / 09期
关键词：
D O I：
10.1128/AAC.00100-07
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The in vitro activity of telavancin was tested against 620 gram-positive isolates. For staphylococci, MICs at which 50 and 90% of isolates were inhibited (MIC50 and MIC90) were both 0.25 mu g/ml, irrespective of methicillin resistance. MIC50 and MIC90 were 0.25 and 0.5 mu g/ml for vancomycin-susceptible enterococci and 1 and 2 mu g/ml for vancomycin-resistant enterococci, respectively. Streptococcus pneumoniae, group A and B beta-hemolytic streptococci, and viridans streptococci were inhibited by <= 0.12 mu g/ml.
引用
收藏
页码：3420 / 3424
页数：5
相关论文
共 50 条
  • [31] Postantibiotic Effects of Telavancin against 16 Gram-Positive Organisms
    Pankuch, G. A.
    Appelbaum, P. C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (03) : 1275 - 1277
  • [32] In vitro activity of tedizolid and comparator agents against clinical Gram-positive isolates recovered from patients with cancer
    Rolston, Kenneth V. I.
    Reitzel, Ruth
    Vargas-Cruz, Nylev
    Shelburne, Samuel A.
    Raad, Issam I.
    Prince, Randall A.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 91 (04) : 351 - 353
  • [33] In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates
    Garcia-Garrote, F
    Cercenado, E
    Alcala, L
    Bouza, E
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) : 2452 - 2455
  • [34] Daptomycin in vitro susceptibility in European Gram-positive clinical isolates
    Fluit, AC
    Schmitz, FJ
    Verhoef, J
    Milatovic, D
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 (01) : 59 - 66
  • [35] Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA and Europe (2014-17)
    Carvalhaes, Cecilia G.
    Sader, Helio S.
    Flamm, Robert K.
    Mendes, Rodrigo E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (07) : 1928 - 1933
  • [36] INVITRO ACTIVITY OF TEICHOMYCIN AGAINST ISOLATES OF GRAM-POSITIVE BACTERIA
    FIETTA, A
    BERSANI, C
    MANGIAROTTI, P
    GRASSI, GG
    CHEMOTHERAPY, 1983, 29 (04) : 275 - 282
  • [37] In vitro activity of levofloxacin against gram-positive bacteria
    Montanari, MP
    Mingoia, M
    Marchetti, F
    Varaldo, PE
    CHEMOTHERAPY, 1999, 45 (06) : 411 - 417
  • [38] In vitro activity of teicoplanin against gram-positive cocci
    Allouch, P
    Pina, P
    Chaplain, C
    Delarbre, JM
    Geffroy, F
    Grasmick, CP
    Marcolin, M
    Morel, A
    Pangon, B
    Rio, Y
    Sédaillan, A
    PATHOLOGIE BIOLOGIE, 2000, 48 (08): : 792 - 795
  • [39] ACTIVITY OF VANCOMYCIN AGAINST RECENTLY ISOLATED NOSOCOMIAL GRAM-POSITIVE COCCI
    MACCANTI, O
    BONADIO, M
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1992, 18 (07) : 295 - 297
  • [40] Daptomycin Activity Tested Against Linezolid-Nonsusceptible Gram-Positive Clinical Isolates
    Mendes, Rodrigo E.
    Jones, Ronald N.
    Deshpande, Lalitagauri M.
    Ross, James E.
    Sader, Helio S.
    MICROBIAL DRUG RESISTANCE, 2009, 15 (04) : 245 - 249
12345